Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress in adjuvant systemic therapy for breast cancer
Noam Pondé, Dimitrios Zardavas, Martine Piccart
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 1, pp. 27-44
Closed Access | Times Cited: 243

Showing 1-25 of 243 citing articles:

Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers
Robert Roskoski
Pharmacological Research (2018) Vol. 139, pp. 395-411
Closed Access | Times Cited: 393
CircRNA inhibits DNA damage repair by interacting with host gene
Xiaolong Xu, Jingwei Zhang, Yihao Tian, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 282
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
Paolo Tarantino, Biagio Ricciuti, Shan M. Pradhan, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 8, pp. 558-576
Open Access | Times Cited: 114
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Huailiang Wu, Yue Gong, Peng Ji, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 106
Senescent Stromal Cells Promote Cancer Resistance through SIRT1 Loss-Potentiated Overproduction of Small Extracellular Vesicles
Han Liu, Qilai Long, Shenjun Li, et al.
Cancer Research (2020) Vol. 80, Iss. 16, pp. 3383-3398
Open Access | Times Cited: 73
A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
Kaiming Zhang, Liqin Ping, Tian Du, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 66
Nanoheterojunction‐Mediated Thermoelectric Strategy for Cancer Surgical Adjuvant Treatment and β‐Elemene Combination Therapy
Xiaoyuan Ji, Zhongmin Tang, Haijun Liu, et al.
Advanced Materials (2022) Vol. 35, Iss. 8
Closed Access | Times Cited: 59
Manganese-enriched photonic/catalytic nanomedicine augments synergistic anti-TNBC photothermal/nanocatalytic/immuno-therapy via activating cGAS-STING pathway
Yi Zheng, Jing Chen, Xinran Song, et al.
Biomaterials (2022) Vol. 293, pp. 121988-121988
Open Access | Times Cited: 41
Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy
Yi Cao, Bin Qiao, Qiaoqi Chen, et al.
Acta Biomaterialia (2023) Vol. 160, pp. 239-251
Closed Access | Times Cited: 39
RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer
Zhi Xu, Xiumei Wang, Wenbo Sun, et al.
Redox Biology (2023) Vol. 68, pp. 102952-102952
Open Access | Times Cited: 24
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future
Amit G. Singal, Mark Yarchoan, Adam C. Yopp, et al.
Hepatology Communications (2024) Vol. 8, Iss. 6
Open Access | Times Cited: 10
Impact of Pre-Existing Frailty on Cardiotoxicity Among Breast Cancer Patients Receiving Adjuvant Therapy
Shuang Yang, Xiwei Lou, Mustafa M. Ahmed, et al.
JACC CardioOncology (2025)
Open Access | Times Cited: 1
Emerging Technologies for Local Cancer Treatment
Corrine Ying Xuan Chua, Jeremy Ho, Sandra Demaria, et al.
Advanced Therapeutics (2020) Vol. 3, Iss. 9
Open Access | Times Cited: 67
Molecular Residual Disease and Adjuvant Trial Design in Solid Tumors
Maria Coakley, Isaac García-Murillas, Nicholas C. Turner
Clinical Cancer Research (2019) Vol. 25, Iss. 20, pp. 6026-6034
Open Access | Times Cited: 62
Expression pattern of m6A regulators is significantly correlated with malignancy and antitumor immune response of breast cancer
Xiaofang He, Liqiang Tan, Jing Ni, et al.
Cancer Gene Therapy (2020) Vol. 28, Iss. 3-4, pp. 188-196
Open Access | Times Cited: 57
3D printed intelligent scaffold prevents recurrence and distal metastasis of breast cancer
Xuelei Shi, Yanxiang Cheng, Jian Wang, et al.
Theranostics (2020) Vol. 10, Iss. 23, pp. 10652-10664
Open Access | Times Cited: 55
Melatonin: A Potential Therapeutic Option for Breast Cancer
Xiangyi Kong, Ran Gao, Zhongzhao Wang, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 11, pp. 859-871
Closed Access | Times Cited: 52
Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer
Jin Zhou, YU Cheng-hao, Cheng Peng
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 34
Neutrophil extracellular traps (NETs)-related lncRNAs signature for predicting prognosis and the immune microenvironment in breast cancer
Tongchao Jiang, Ying Wang, Xiaoyu Chen, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 21
Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy
Yuntong Sun, Fengtian Sun, Wenrong Xu, et al.
Tissue Engineering and Regenerative Medicine (2023) Vol. 20, Iss. 2, pp. 157-175
Open Access | Times Cited: 20
Circulating Tumor DNA in the Management of Early-Stage Breast Cancer
Katerina Vlataki, Sevastiani Antonouli, C. Kalyvioti, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1573-1573
Open Access | Times Cited: 18
Mindfulness-Based Stress Reduction for Quality of Life, Psychological Distress, and Cognitive Emotion Regulation Strategies in Patients With Breast Cancer Under Early Chemotherapy—a Randomized Controlled Trial
Pingting Zhu, Xinyi Liu, Xingchen Shang, et al.
Holistic Nursing Practice (2023) Vol. 37, Iss. 3, pp. 131-142
Closed Access | Times Cited: 17
Biomimetic Nanomedicine Targeting Orchestrated Metabolism Coupled with Regulatory Factors to Disrupt the Metabolic Plasticity of Breast Cancer
Lingtong Meng, Jingpeng Yang, Yang Gao, et al.
ACS Nano (2024) Vol. 18, Iss. 5, pp. 4360-4375
Closed Access | Times Cited: 6
Axillary Surgery for Breast Cancer in 2024
Martin Heidinger, William P. Weber
Cancers (2024) Vol. 16, Iss. 9, pp. 1623-1623
Open Access | Times Cited: 6
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials
Evandro de Azambuja, Noam Pondé, Marion Procter, et al.
Breast Cancer Research and Treatment (2019) Vol. 179, Iss. 1, pp. 161-171
Open Access | Times Cited: 52
Page 1 - Next Page

Scroll to top